McCormick & Company
MKC
$52.02
-0.63%
McCormick & Company is the world's leading manufacturer of spices, herbs, seasonings, and flavorings, operating in the packaged foods industry. Its portfolio includes iconic brands such as Old Bay, Frank's RedHot, French's, and Cholula, giving it a dominant position in the global flavor market. The current investor narrative centers on McCormick's transformative $45 billion acquisition of Unilever's food business (Knorr, Hellmann's), which has sparked intense debate about integration risks, debt levels, and the potential to create a $20 billion flavor giant. Recent news highlights skepticism over the deal's execution, with the stock hitting a 52-week low despite strong quarterly earnings.…
MKC
McCormick & Company
$52.02
Related headlines
Investment Opinion: Should I buy MKC Today?
Rating: Hold. Thesis: McCormick is a high-conviction hold for risk-tolerant investors, as the Unilever acquisition creates a binary outcome with significant upside potential but equally large downside risks. The analyst consensus is Buy with an average target of $60.23, implying 16.5% upside, but the stock's 27.9% annual decline and near 52-week low suggest the market is pricing in substantial deal risk. Supporting evidence: The forward P/E of 15.6x is a 22% discount to the industry average of 20x, revenue grew 16.7% YoY in Q2 2026, gross margin expanded to 40.2%, and free cash flow of $1.16B TTM provides a cushion. However, the trailing P/E of 22.6x is still a 13% premium to peers, and the current ratio of 0.70 is weak. Risks & Conditions: The biggest risks are integration failure of the Unilever deal, margin compression from higher debt costs, and a prolonged downturn in consumer spending. This Hold would upgrade to Buy if the stock falls below $45 (near 52-week low) or if the company provides clear evidence of synergy realization, such as cost savings exceeding $500 million. It would downgrade to Sell if revenue growth decelerates below 10% or if debt-to-equity rises above 1.5. Valuation verdict: The stock is fairly valued to slightly undervalued based on forward P/E, but overvalued on trailing P/E relative to history.
Sign up to view all
MKC 12-Month Price Forecast
McCormick is at a pivotal juncture with the Unilever acquisition. The forward valuation is attractive, but the stock's poor price performance and high deal risk warrant caution. The base case of gradual integration and modest upside to $60 is most likely, but the wide range of outcomes (from $44 to $75) reflects binary risk. I would upgrade to bullish if the deal closes with clear margin guidance above 42%, and downgrade to bearish if revenue growth falls below 10% or debt-to-equity exceeds 1.5. For now, neutral with medium confidence.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on McCormick & Company's 12-month outlook, with a consensus price target around $60.62 and implied upside of +16.5% versus the current price.
Average Target
$60.62
0 analysts
Implied Upside
+16.5%
vs. current price
Analyst Count
—
covering this stock
Price Range
$52 - $75
Analyst target range
McCormick is covered by 13 analysts, with a consensus recommendation of Buy and a mean recommendation score of 2.13 (where 1 is Strong Buy and 5 is Sell). The average target price is $60.23, implying 16.5% upside from the current price of $51.70. The distribution leans bullish, with firms like TD Cowen, Deutsche Bank, and JP Morgan maintaining Buy/Overweight ratings, while Barclays and UBS are more cautious with Equal Weight/Neutral. The target price range spans from a low of $51.00 to a high of $75.00. The high target of $75 assumes successful integration of the Unilever deal, margin expansion, and revenue growth, while the low target of $51 reflects risks of execution failure, margin compression, or a prolonged downturn. The spread of $24 between low and high indicates high uncertainty, consistent with the transformative nature of the acquisition. Recent ratings have been stable, with no major downgrades or upgrades in the past month, suggesting analysts are waiting for more clarity on the deal's progress.
Bulls vs Bears: MKC Investment Factors
McCormick presents a high-risk, high-reward opportunity centered on the Unilever acquisition. On the bull side, the forward P/E of 15.6x is a 22% discount to the industry, revenue growth is accelerating at 16.7%, and analysts see 16.5% upside to the average target of $60.23. On the bear side, the stock has lost 27.9% over the past year, the $45 billion deal introduces significant debt and integration risk, and the trailing P/E of 22.6x is still a premium to peers. The single most important tension is whether management can successfully integrate Unilever's food brands and realize the projected synergies without margin erosion. If they do, the stock could re-rate higher; if not, further downside is likely. Currently, the bear case has stronger evidence given the stock's downtrend and deal skepticism, but the valuation discount offers a compelling entry for patient investors.
Bullish
- Forward P/E at 15.6x is a 22% discount to industry: McCormick's forward P/E of 15.6x is well below the packaged foods industry average of 20x, implying the market is pricing in significant uncertainty. If the Unilever deal succeeds, earnings could grow, and the multiple could expand, offering substantial upside.
- Revenue growth accelerating to 16.7% YoY: In Q2 2026, revenue grew 16.7% year-over-year to $1.94 billion, accelerating from 7.9% in the prior quarter. This growth is partly organic and partly reflects the Unilever acquisition, which could drive further top-line expansion.
- Analyst consensus Buy with 16.5% upside: 13 analysts rate MKC a Buy with an average target of $60.23, implying 16.5% upside from $51.70. The high target of $75 suggests potential for 45% gains if the deal integration goes well.
- Gross margin expanding to 40.2% from 37.5%: Gross margin improved 270 bps year-over-year to 40.2% in Q2 2026, driven by cost savings and pricing. This indicates underlying operational efficiency that could be sustained post-acquisition.
Bearish
- Stock down 27.9% over the past year: MKC has declined 27.9% in the last year, underperforming the S&P 500 by 46.3 percentage points. The stock sits near the bottom of its 52-week range, reflecting deep investor skepticism about the Unilever acquisition.
- Unilever deal adds $45B debt and integration risk: The transformative $45 billion acquisition of Unilever's food business will significantly increase leverage and dilute near-term earnings. Integration risks are high, and any misstep could lead to margin compression or asset write-downs.
- Trailing P/E of 22.6x is a 13% premium to peers: Despite the stock's decline, the trailing P/E of 22.6x is above the industry average of 20x, suggesting the market still prices in some premium for the company's historical stability. This leaves little room for error.
- Current ratio of 0.70 indicates liquidity pressure: With a current ratio of 0.70, McCormick has more short-term liabilities than assets, which could strain liquidity if cash flows weaken. The company relies on operating cash flow to meet obligations.
MKC Technical Analysis
McCormick is in a sustained downtrend, with the stock price declining 27.9% over the past year. The current price of $51.70 sits at 70% of its 52-week range ($44.82 low to $73.84 high), indicating it is closer to the bottom than the top. This positioning suggests the market is pricing in significant uncertainty, likely due to the Unilever acquisition, and the stock may be oversold but still vulnerable to further downside if sentiment deteriorates. Over the past month, the stock has rallied 11.2%, while the 3-month change is -4.8%, showing a short-term bounce from the May low of $45.60. This divergence from the 1-year downtrend could signal a potential reversal, but the 1-month relative strength of +10.9% versus the S&P 500 suggests the bounce is more of a mean-reversion move than a fundamental shift. The 6-month decline of -22.9% confirms the broader bearish trend remains intact. The 52-week low of $44.82 provides key support, while the 52-week high of $73.84 is a major resistance level. A break below $44.82 would signal further downside, potentially toward $40, while a move above $73.84 would indicate a trend reversal. With a beta of 0.63, McCormick is significantly less volatile than the market, meaning the stock's 27.9% annual decline is even more pronounced relative to the S&P 500's 18.4% gain, highlighting company-specific risk.
Beta
0.63
0.63x market volatility
Max Drawdown
-41.2%
Largest decline past year
52-Week Range
$45-$74
Price range past year
Annual Return
-28.2%
Cumulative gain past year
| Period | MKC Return | S&P 500 |
|---|---|---|
| 1m | +13.8% | +0.4% |
| 3m | +0.3% | +5.5% |
| 6m | -14.4% | +8.4% |
| 1y | -28.2% | +18.9% |
| ytd | -22.7% | +9.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MKC Fundamental Analysis
McCormick's revenue grew 16.7% year-over-year in the most recent quarter (Q2 2026) to $1.94 billion, accelerating from the prior quarter's 7.9% growth. The Consumer segment contributed $1.14 billion and Flavor Solutions $794 million, with the acquisition of Unilever's food brands expected to significantly boost future revenue. However, the multi-quarter trend shows revenue growth has been volatile, ranging from 3.5% to 16.7% over the past four quarters, and the pending deal introduces near-term uncertainty. The company is profitable, with net income of $160 million in Q2 2026 and a gross margin of 40.2%, which expanded from 37.5% in the year-ago quarter. Operating margin improved to 14.3% from 14.8% a year earlier, indicating stable cost management. Net margin of 8.3% is typical for the packaged foods industry, though the Unilever deal may pressure margins initially due to integration costs. McCormick has a debt-to-equity ratio of 0.70 and generated $1.16 billion in trailing free cash flow, providing ample liquidity. The current ratio of 0.70 is low, but the company's strong operating cash flow ($380 million in Q2 2026) and manageable debt levels suggest it can service its obligations. ROE of 13.8% is solid, reflecting efficient capital use, though the Unilever acquisition will likely increase leverage and dilute returns in the near term.
Quarterly Revenue
$1.9B
2026-05
Revenue YoY Growth
+16.7%
YoY Comparison
Gross Margin
40.2%
Latest Quarter
Free Cash Flow
$1.2B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MKC Overvalued?
Since net income is positive, the primary valuation metric is the P/E ratio. The trailing P/E is 22.6x, while the forward P/E is 15.6x, implying the market expects earnings to grow significantly next year. The gap between trailing and forward P/E suggests the market is pricing in a recovery in earnings, likely driven by the Unilever deal synergies. Compared to the packaged foods industry average P/E of approximately 20x, McCormick's trailing P/E of 22.6x represents a 13% premium. However, the forward P/E of 15.6x is a 22% discount to the industry forward average of 20x, indicating that the market is already discounting future earnings growth. This divergence reflects uncertainty around the deal's execution and potential dilution. Historically, McCormick's trailing P/E has ranged from 20x to 53x over the past five years. The current 22.6x is near the lower end of that range, suggesting the stock is cheap relative to its own history. The P/B ratio of 3.1x is also below the 5-year average of 4.5x, reinforcing the view that the stock is trading at a discount to its historical valuation.
PE
22.6x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 20x~41x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
16.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: McCormick's pending $45 billion acquisition of Unilever's food business will substantially increase its debt load, with the debt-to-equity ratio already at 0.70. Integration costs could pressure margins, which are currently at 40.2% gross margin and 14.3% operating margin. The company's current ratio of 0.70 indicates potential liquidity constraints, though $1.16 billion in trailing free cash flow provides a buffer. Revenue concentration in the Consumer segment (59% of sales) and reliance on the success of the deal add operational risk. Market & Competitive Risks: The stock's beta of 0.63 suggests lower market correlation, but the 27.9% annual decline reflects company-specific risk. Valuation compression is a concern if the forward P/E of 15.6x fails to expand as expected. Competitive threats from other packaged food giants like Kraft Heinz and Nestlé could intensify, especially if McCormick's focus shifts to integration. Regulatory scrutiny of the mega-deal could delay or impose conditions. Worst-Case Scenario: If the Unilever deal faces execution failures, such as margin erosion, customer losses, or antitrust hurdles, the stock could fall to its 52-week low of $44.82, representing a 13.3% decline from the current price of $51.70. In a severe recession or deal collapse, the stock could drop to $40, a 22.6% loss, based on historical max drawdown of 41.2% from the 52-week high of $73.84.
FAQ
The primary risk is integration failure of the $45 billion Unilever acquisition, which could lead to margin compression, asset write-downs, and a stock decline to the 52-week low of $44.82 (13.3% downside). Financial risks include a debt-to-equity ratio of 0.70 that could rise further, and a current ratio of 0.70 indicating potential liquidity strain. Competitive risks include pressure from larger players like Nestlé and Kraft Heinz, especially if McCormick's focus shifts during integration. Macro risks include rising interest rates increasing debt costs and a consumer slowdown affecting demand. The stock's beta of 0.63 offers some insulation from market swings, but company-specific risks dominate.
The 12-month forecast is highly uncertain, with three scenarios: Bull case (25% probability) sees the stock reaching $65-$75 if the Unilever deal succeeds and margins expand. Base case (50% probability) targets $55-$65 as integration progresses gradually, aligning with the analyst average of $60.23. Bear case (25% probability) sees the stock falling to $44-$51 if the deal faces delays or cost overruns. The most likely scenario is the base case, assuming the deal closes and margins stabilize. Key assumptions include revenue growth of 12-15% and gross margins around 40%. Investors should monitor earnings reports for deal updates.
MKC appears undervalued on a forward basis but overvalued on a trailing basis. The forward P/E of 15.6x is a 22% discount to the packaged foods industry average of 20x, suggesting the market is pricing in significant risk. However, the trailing P/E of 22.6x is a 13% premium to the industry, indicating that past earnings are not cheap. Historically, MKC's trailing P/E has ranged from 20x to 53x over five years, so the current 22.6x is near the lower end. The P/B ratio of 3.1x is also below the 5-year average of 4.5x. Overall, the stock is cheap relative to its own history and forward earnings, but the discount reflects the uncertainty of the Unilever deal.
MKC is a high-risk, high-reward buy for investors who believe the Unilever acquisition will succeed. The stock offers a forward P/E of 15.6x, a 22% discount to the industry, and analysts see 16.5% upside to the average target of $60.23. However, the stock has declined 27.9% over the past year and trades near its 52-week low, reflecting deep skepticism. The biggest downside risk is integration failure, which could push the stock to $44.82 or lower. For risk-tolerant investors with a long-term horizon, it could be a good buy at current levels, but conservative investors should wait for more clarity on the deal.
MKC is better suited for long-term investment (3-5 years) due to the binary nature of the Unilever acquisition. Short-term trading is risky given the stock's 27.9% annual decline and high volatility relative to its beta of 0.63. The stock offers a 2.7% dividend yield, providing some income for long-term holders. Earnings visibility is low until the deal closes, so short-term catalysts are limited. A minimum holding period of 12-18 months is recommended to allow the deal to progress and synergies to materialize. Patient investors could benefit from the forward P/E discount, but short-term traders should wait for a clearer trend.